Taiana Elisa

Type B Postdoctoral Fellow

Contacts

Workplace

Via Francesco Sforza, 35 - Ospedale Maggiore Policlinico - Pad. Marcora
20122 MILANO (MI)

University email address
Research

Publications

Publications
  • DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome / K. Todoerti, D. Ronchetti, V. Favasuli, F. Maura, F. Morabito, N. Bolli, E. Taiana, A. Neri. - In: HAEMATOLOGICA. - ISSN 1592-8721. - (2021 May 06). [Epub ahead of print]
  • Genomic instability in multiple myeloma: A “non‐coding rna” perspective / E. Taiana, M.E.G. Cantafio, V.K. Favasuli, C. Bandini, G. Viglietto, R. Piva, A. Neri, N. Amodio. - In: CANCERS. - ISSN 2072-6694. - 13:9(2021 May).
  • Epigenetic Regulation of Mitochondrial Quality Control Genes in Multiple Myeloma: A Sequenom MassARRAY Pilot Investigation on HMCLs / P. D'Aquila, D. Ronchetti, M.E. Gallo Cantafio, K. Todoerti, E. Taiana, F. Fabiani, A. Montesanto, A. Neri, G. Passarino, G. Viglietto, D. Bellizzi, N. Amodio. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 10:6(2021 Mar 21).
  • Antitumor Effects of PRIMA-1 and PRIMA-1Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair? / P. Menichini, P. Monti, A. Speciale, G. Cutrona, S. Matis, F. Fais, E. Taiana, A. Neri, R. Bomben, M. Gentile, V. Gattei, M. Ferrarini, F. Morabito, G. Fronza. - In: CELLS. - ISSN 2073-4409. - 10:1(2021 Jan 07).
  • The landscape of signaling pathways and proteasome inhibitors combinations in multiple myeloma / T. Paradzik, C. Bandini, E. Mereu, M. Labrador, E. Taiana, N. Amodio, A. Neri, R. Piva. - In: CANCERS. - ISSN 2072-6694. - 13:6(2021), pp. 1235.1-1235.34.